Soleno Therapeutics Inc’s recent filing unveils that its 10% Owner Vivo Opportunity, LLC unloaded Company’s shares for reported $74.58 million on Mar 27 ’25. In the deal valued at $67.80 per share,1,100,000 shares were sold. As a result of this transaction, Vivo Opportunity, LLC now holds 4,791,851 shares worth roughly $344.97 million.
Then, Vivo Opportunity, LLC sold 400,000 shares, generating $26,320,000 in total proceeds. Upon selling the shares at $65.80, the 10% Owner now owns 5,891,851 shares.
Before that, Vivo Opportunity, LLC sold 333,557 shares. Soleno Therapeutics Inc shares valued at $23,549,124 were divested by the 10% Owner at a price of $70.60 per share. As a result of the transaction, Vivo Opportunity, LLC now holds 4,458,294 shares, worth roughly $320.95 million.
A number of analysts have revised their coverage, including Stifel’s analysts, who remained covering the stock and in early December has reiterated a ‘”a Buy”‘ rating for it. Robert W. Baird also remained covering SLNO and reiterated its “an Outperform” recommendation on December 02, 2024. H.C. Wainwright started covering the stock on September 03, 2024. It rated SLNO as “a Buy”.
Price Performance Review of SLNO
On Friday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock jump 6.83% to $71.99. Over the last five days, the stock has gained 46.59%. Soleno Therapeutics Inc shares have risen nearly 60.16% since the year began. Nevertheless, the stocks have risen 66.64% over the past one year. While a 52-week high of $72.96 was reached on 03/28/25, a 52-week low of $36.61 was recorded on 01/15/25. SMA at 50 days reached $48.88, while 200 days put it at $48.89.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 67.94, which if violated will result in even more drops to 63.88. On the upside, there is a resistance level at 75.01. A further resistance level may holdings at 78.02. The Relative Strength Index (RSI) on the 14-day chart is 84.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 11.04, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.39%. Stochastics %K at 80.75% indicates the stock is a selling.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on 2025-03-14, growing by 0.45 million shares to a total of 4.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 4.54 million shares. There was a rise of 8.97%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 10, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $72 price target.
